Virus-tracking app plans hit setbacks

“Now is not the time for parties, nightlife, getting together in crowds

DOUBTS were growing yesterday over whether ambitious plans by European governments to use contact-tracing apps to fight the spread of the coronavirus will be able to be implemented with any real effectiveness soon.

In contrast, there appeared to be some movement forward in the sprint to find a vaccine against Covid-19, bolstered by a $1 billion (R17.7bn) investment from the US vaccine agency.

British Prime Minister Boris Johnson pledged on Wednesday to have a “test, track and trace” programme for Covid-19 in place by June 1 as part of a strategy to persuade the country that it’s safe to move on to the next stage of easing the lockdown and restarting the economy. But the government also appeared to backtrack on an earlier pledge to make a smartphone app a pillar of that programme.

Security minister James Brokenshire said yesterday that he remains “confident” that the tracing system will be in place by June 1, but acknowledged that an app intended to help track the virus was not ready. He suggested “technical issues” were the reason for its failure to be introduced as planned by the middle of this month.

An effective system is now seen as crucial to preventing a deadly second wave of the outbreak – and thus getting the economy working again after the lockdown.

Experts say that being able to quickly identify people exposed to the virus can help stop the spread of the contagious respiratory illness, but efforts to put apps in place have come up across technical problems and fears of privacy intrusions.

The French government has also been forced to delay deployment of its planned contact-tracing app. Initially expected last week as the country started lifting confinement measures, it won’t be ready before next month due to technical issues and concerns over privacy. Italian Premier Giuseppe Conte said yesterday that its contact-tracing app would begin tests “in the coming days”. But he made no mention of whether Italy had hired teams of contact-tracers to actually conduct interviews and get in touch with people who had been in contact with Covid-19 patients, as other European countries have done.

Spain’s Economy Minister Nadia Calviño said on Wednesday in parliament that Spain is making preparations to test a European Bluetooth-based app at the end of next month in the Canary Islands. But the adoption of the app has taken a back seat to the hiring of old-school human tracers in Spain. The government has said that the technology would be adopted only if it adds value to the tracing efforts that are being deployed by 17 regional administrations.

Meanwhile, drug maker AstraZeneca said yesterday it has secured the first agreements for 400 million doses of a Covid-19 vaccine that is now being tested at the University of Oxford, one of the most advanced projects in the search for a vaccine.

The Anglo-Swedish company reported it had received more than $1bn from the US Biomedical Advanced Research and Development Authority for the development, production and delivery of the vaccine, starting this autumn. AstraZeneca chief executive Pascal Soriot said the company “will do everything in our power to make this vaccine quickly and widely available”.

Around the world, the effort to get back to business is raising worries over risks of new infections. In Italy, one of Europe’s worst-hit countries, authorities warned that people are violating social-distancing guidelines after a strict lockdown was lifted threatened the country’s recovery.

“Now is not the time for parties, nightlife and getting together in crowds,” Conte warned in parliament. “Be careful. Because exposing yourselves to contagion means exposing your loved ones to contagion.”

Cases in Milan, the seat of the hard-hit region of Lombardy, are rising as Italy continues to relax its long lockdown. Since Sunday, there have been 137 new cases in the city of 1.4 million residents.

From meatpacking plants in Colorado, US, to garment factories in Bangladesh, workers are concerned over risks they face as they return to work after shutdowns.